kabutan

Shionogi & Co.,Ltd.(4507) Summary

4507
TSE Prime
Shionogi & Co.,Ltd.
3,409.0
JPY
+5.0
(+0.15%)
Mar 13, 3:30 pm JST
21.38
USD
Mar 13, 2:30 am EDT
Result
PTS
outside of trading hours
3,407
Mar 13, 10:56 pm JST
Summary Chart Historical News Financial Result
PER
15.4
PBR
1.92
Yield
1.94%
Margin Trading Ratio
14.47
Stock Price
Mar 13, 2026
Opening Mar 13, 9:00 am
3,358.0 JPY 21.08 USD
Previous Close Mar 12
3,404.0 JPY 21.41 USD
High Mar 13, 9:16 am
3,442.0 JPY 21.64 USD
Low Mar 13, 9:00 am
3,358.0 JPY 21.08 USD
Volume
2,664,700
Trading Value
9.05B JPY 0.06B USD
VWAP
3395.46 JPY 21.3 USD
Minimum Trading Value
340,900 JPY 2,138 USD
Market Cap
3.03T JPY 0.02T USD
Number of Trades
3,505
Liquidity & Number of Trades
As of Mar 13, 2026
Liquidity
High
1-Year Average
4,576
1-Year High Apr 7, 2025
13,762
Margin Trading
Date Short Interest Long Margin Positions Ratio
Mar 6, 2026 187,600 827,000 4.41
Feb 27, 2026 203,600 848,300 4.17
Feb 20, 2026 226,100 914,300 4.04
Feb 13, 2026 236,600 893,700 3.78
Feb 6, 2026 265,800 922,100 3.47
Company Profile
Shionogi & Co., Ltd. has seen significant growth in its anti-HIV drugs. The company has strengths in hyperlipidemia medications, pain management, and the infection field. It is also accelerating its expansion into overseas markets.
Sector
Pharmaceuticals
Shionogi & Co., Ltd. engages in the research and development, procurement, manufacturing, and sales of prescription pharmaceuticals, with a particular strength in the field of infectious diseases. The company has numerous subsidiaries and affiliated companies both domestically and internationally, enabling a global business operation. Key subsidiaries include Shionogi Pharma, which handles manufacturing and contract manufacturing; Shionogi Healthcare, which develops OTC pharmaceutical business; and Shionogi TechnoAdvance Research, which provides research support for drug discovery. Overseas, Shionogi has established bases primarily in the United States, as well as in Europe and Asia, to promote local research and development and sales activities. In China, in particular, the company operates through multiple subsidiaries, demonstrating its active pursuit of expansion into foreign markets.